Here are 10 things to know from the company’s financial report:
1. NuVasive reported net income at $20 million on a non-GAAP basis, or $0.39 per share, for the fourth quarter. For the full year, the net income on a non-GAAP basis was $57.5 million, or $1.16 per share. This is relatively flat over 2013.
2. Fourth quarter revenue reached $204.3 million, a 7.1 percent increase over the same period last year. The full year net revenue reached $762.4 million, an 11.3 percent increase over 2013.
3. Full year total revenue was up 11.6 percent on a constant currency basis over 2013.
4. GAAP operating expenses for the fourth quarter was $133.3 million, up slightly over the same period last year. The total GAAP operating expenses for the full year was $561.9 million in 2014, compared to $471.6 million in 2013.
5. Cash, cash equivalents and short and long-term marketable securities were around $405.8 million at Dec. 31, 2014.
6. NuVasive generated $19.1 million in cash flow operations in the fourth quarter. For the full year, the company generated $115.5 million in cash flow from operations.
7. The company invested $12.7 million in capital expenditures. The full year capital expenditure investment was $58.2 million.
8. NuVasive expects revenue to hit around $810 million in 2015, including around $10 million of currency headwinds. This would be a 6 percent growth when compared with 2014.
9. The company expects GAAP earnings per share around $0.67, which is a $0.36 loss per share compared with 2014.
10. NuVasive expects 2015 Non-GAAP operating margin of around 14.4 percent, an increase of around 300 basis points compared to 2014.
More articles on spine devices:
NuVasive’s partes review gets final decision
5 things to know about Spineology’s suit against Wright Medical
OrthAlign appoints Gary Henley board of directors’ executive chairman
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
